Detalles de la búsqueda
1.
Long-Term Ticagrelor in Patients With Prior Coronary Stenting in the PEGASUS-TIMI 54 Trial.
J Am Heart Assoc
; 10(17): e020446, 2021 09 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34423649
2.
Plasma N-terminal fragment of the prohormone B-type natriuretic peptide concentrations in relation to time to treatment and Thrombolysis in Myocardial Infarction (TIMI) flow: a substudy of the Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT IV-PCI) trial.
Am Heart J
; 159(1): 131-40, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20102879
3.
Prediction of cardiogenic shock using plasma B-type natriuretic peptide and the N-terminal fragment of its pro-hormone [corrected] concentrations in ST elevation myocardial infarction: an analysis from the ASSENT-4 Percutaneous Coronary Intervention Trial.
Crit Care Med
; 38(9): 1793-801, 2010 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-20562693
4.
Reperfusion before percutaneous coronary intervention in ST-elevation myocardial infarction patients is associated with lower N-terminal pro-brain natriuretic peptide levels during follow-up, irrespective of pre-treatment with full-dose fibrinolysis.
Eur Heart J
; 30(18): 2213-9, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19586960
5.
Transfusion and mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Eur Heart J
; 30(21): 2575-83, 2009 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19596659
6.
ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
Circulation
; 118(13): 1335-46, 2008 Sep 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-18779444
7.
Patients with prolonged ischemic chest pain and presumed-new left bundle branch block have heterogeneous outcomes depending on the presence of ST-segment changes.
J Am Coll Cardiol
; 46(1): 29-38, 2005 Jul 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-15992631
8.
Age, outcomes, and treatment effects of fibrinolytic and antithrombotic combinations: findings from Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT)-3 and ASSENT-3 PLUS.
Am Heart J
; 152(4): 684.e1-9, 2006 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-16996833
9.
Chlamydia pneumoniae induces neointima formation in coronary arteries of normal pigs.
Cardiovasc Res
; 57(3): 834-42, 2003 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-12618245
10.
Efficacy of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: one-year follow-up results of the Assessment of the Safety of a New Thrombolytic-3 (ASSENT-3) randomized trial in acute myocardial infarction.
Am Heart J
; 147(6): 993-8, 2004 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-15199346
11.
Fine-tuning the selection of a reperfusion strategy.
Circulation
; 114(19): 2002-3, 2006 Nov 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-17088472
12.
Cardiovascular disease on a global scale: defining the path forward for research and practice.
Eur Heart J
; 28(21): 2678-84, 2007 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-17940081
13.
Global patterns of health care for acute coronary syndromes.
Curr Opin Cardiol
; 19(6): 625-30, 2004 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-15502510
Resultados
1 -
13
de 13
1
Próxima >
>>